Daniel Gonzalez

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 47

Top Venues

Clinical pharmacokinetics

CPT: pharmacometrics & systems pharmacology

Clinical and translational science

Journal of clinical pharmacology

University of North Carolina at Chapel Hill

University of Florida (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of North Carolina at Chapel Hill

United States

Associate Professor :: UNC Eshelman School of Pharmacy

Education History

University of Florida

United States

PHD :: College of Pharmacy

University of Florida

United States

PHD :: College of Pharmacy

Publications

Patricia D Maglalang, Jiali Wen, Christoph P Hornik, Daniel Gonzalez
Sources of pharmacokinetic and pharmacodynamic variability and clinical pharmacology studies of antiseizure medications in the pediatric population. Clinical and translational science 17 (4) (2024)
Elizabeth J Thompson, Angela Jeong, Victória Etges Helfer, Valentina Shakhnovich, Andrea N Edginton, Stephen J Balevic, Laura P James, David N Collier, Ravinder Anand, Daniel Gonzalez, null null
Physiologically-based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population. CPT: pharmacometrics & systems pharmacology (2024)
Khalid Altigani Awad Alkarem Ahmed, Alnada Ibrahim, Daniel Gonzalez, Abubakr O Nur
Population Pharmacokinetics and Model-Based Dose Optimization of Vancomycin in Sudanese Adult Patients with Renal Impairment. Drug design, development and therapy 18 (2024)
Elizabeth J Thompson, Angela Jeong, Victória Etges Helfer, Valentina Shakhnovich, Andrea N Edginton, Stephen J Balevic, Laura P James, David N Collier, Ravinder Anand, Daniel Gonzalez, null null
Physiologically-based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population. CPT: pharmacometrics & systems pharmacology 13 (8) (2024)
Patricia D Maglalang, Jaydeep Sinha, Kanecia O Zimmerman, Sean McCann, Andrea N Edginton, Christoph P Hornik, Chi D Hornik, William J Muller, Amira Al-Uzri, Marisa Meyer, Jia-Yuh Chen, Ravinder Anand, Eliana M Perrin, Daniel Gonzalez, null null
Application of Physiologically Based Pharmacokinetic Modeling to Characterize the Effects of Age and Obesity on the Disposition of Levetiracetam in the Pediatric Population. Clinical pharmacokinetics 63 (6) (2024)
Patricia D Maglalang, Jaydeep Sinha, Kanecia O Zimmerman, Sean McCann, Andrea N Edginton, Christoph P Hornik, Chi D Hornik, William J Muller, Amira Al-Uzri, Marisa Meyer, Jia-Yuh Chen, Ravinder Anand, Eliana M Perrin, Daniel Gonzalez, null null
Application of Physiologically Based Pharmacokinetic Modeling to Characterize the Effects of Age and Obesity on the Disposition of Levetiracetam in the Pediatric Population. Clinical pharmacokinetics (2024)
Patricia D Maglalang, Jaydeep Sinha, Kanecia O Zimmerman, Sean McCann, Andrea N Edginton, Christoph P Hornik, Chi D Hornik, William J Muller, Amira Al-Uzri, Marisa Meyer, Jia-Yuh Chen, Ravinder Anand, Eliana M Perrin, Daniel Gonzalez, null null
Application of Physiologically Based Pharmacokinetic Modeling to Characterize the Effects of Age and Obesity on the Disposition of Levetiracetam in the Pediatric Population. Clinical pharmacokinetics 63 (6) (2024)
Fernando O Carreño, Jacqueline G Gerhart, Victória Etges Helfer, Jaydeep Sinha, Karan R Kumar, Carl M J Kirkpatrick, Christoph P Hornik, Daniel Gonzalez, null null
Characterizing Enoxaparin's Population Pharmacokinetics to Guide Dose Individualization in the Pediatric Population. Clinical pharmacokinetics 63 (7) (2024)
Elizabeth J Thompson, Angela Jeong, Victória Etges Helfer, Valentina Shakhnovich, Andrea N Edginton, Stephen J Balevic, Laura P James, David N Collier, Ravinder Anand, Daniel Gonzalez, null null
Physiologically-based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population. CPT: pharmacometrics & systems pharmacology 13 (8) (2024)
Fernando O Carreño, Jacqueline G Gerhart, Victória Etges Helfer, Jaydeep Sinha, Karan R Kumar, Carl M J Kirkpatrick, Christoph P Hornik, Daniel Gonzalez, null null
Characterizing Enoxaparin's Population Pharmacokinetics to Guide Dose Individualization in the Pediatric Population. Clinical pharmacokinetics 63 (7) (2024)
Elizabeth J Thompson, Angela Jeong, Victória Etges Helfer, Valentina Shakhnovich, Andrea N Edginton, Stephen J Balevic, Laura P James, David N Collier, Ravinder Anand, Daniel Gonzalez, null null
Physiologically-based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population. CPT: pharmacometrics & systems pharmacology (2024)
Khalid Altigani Awad Alkarem Ahmed, Alnada Ibrahim, Daniel Gonzalez, Abubakr O Nur
Population Pharmacokinetics and Model-Based Dose Optimization of Vancomycin in Sudanese Adult Patients with Renal Impairment. Drug design, development and therapy 18 (2024)
Fernando O Carreño, Jacqueline G Gerhart, Victória Etges Helfer, Jaydeep Sinha, Karan R Kumar, Carl M J Kirkpatrick, Christoph P Hornik, Daniel Gonzalez, null null
Characterizing Enoxaparin's Population Pharmacokinetics to Guide Dose Individualization in the Pediatric Population. Clinical pharmacokinetics (2024)
Fernando O Carreño, Jacqueline G Gerhart, Victória Etges Helfer, Jaydeep Sinha, Karan R Kumar, Carl M J Kirkpatrick, Christoph P Hornik, Daniel Gonzalez, null null
Characterizing Enoxaparin's Population Pharmacokinetics to Guide Dose Individualization in the Pediatric Population. Clinical pharmacokinetics (2024)
Jiali Wen, Sean McCann, Stephen J Balevic, William J Muller, Chi D Hornik, Julie Autmizguine, Sarah G Anderson, Elizabeth H Payne, Sitora Turdalieva, Daniel Gonzalez, null null
Pharmacokinetics of Dexamethasone in Children and Adolescents with Obesity. Journal of clinical pharmacology (2024)
Patricia D Maglalang, Jiali Wen, Christoph P Hornik, Daniel Gonzalez
Sources of pharmacokinetic and pharmacodynamic variability and clinical pharmacology studies of antiseizure medications in the pediatric population. Clinical and translational science 17 (4) (2024)
Elizabeth J Thompson, Angela Jeong, Victória Etges Helfer, Valentina Shakhnovich, Andrea N Edginton, Stephen J Balevic, Laura P James, David N Collier, Ravinder Anand, Daniel Gonzalez, null null
Physiologically-based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population. CPT: pharmacometrics & systems pharmacology (2024)
Elizabeth J Thompson, Angela Jeong, Victória Etges Helfer, Valentina Shakhnovich, Andrea N Edginton, Stephen J Balevic, Laura P James, David N Collier, Ravinder Anand, Daniel Gonzalez, null null
Physiologically-based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population. CPT: pharmacometrics & systems pharmacology 13 (8) (2024)
Jiali Wen, Sean McCann, Stephen J Balevic, William J Muller, Chi D Hornik, Julie Autmizguine, Sarah G Anderson, Elizabeth H Payne, Sitora Turdalieva, Daniel Gonzalez, null null
Pharmacokinetics of Dexamethasone in Children and Adolescents with Obesity. Journal of clinical pharmacology (2024)
Eleni Karatza, Jaydeep Sinha, Patricia D Maglalang, Andrea N Edginton, Daniel Gonzalez
Physiologically-Based Pharmacokinetic Modeling of Total and Unbound Valproic Acid to Evaluate Dosing in Children With and Without Hypoalbuminemia. Clinical pharmacokinetics (2024)
Patricia D Maglalang, Jaydeep Sinha, Kanecia O Zimmerman, Sean McCann, Andrea N Edginton, Christoph P Hornik, Chi D Hornik, William J Muller, Amira Al-Uzri, Marisa Meyer, Jia-Yuh Chen, Ravinder Anand, Eliana M Perrin, Daniel Gonzalez, null null
Application of Physiologically Based Pharmacokinetic Modeling to Characterize the Effects of Age and Obesity on the Disposition of Levetiracetam in the Pediatric Population. Clinical pharmacokinetics 63 (6) (2024)
Fernando O Carreño, Jacqueline G Gerhart, Victória Etges Helfer, Jaydeep Sinha, Karan R Kumar, Carl M J Kirkpatrick, Christoph P Hornik, Daniel Gonzalez, null null
Characterizing Enoxaparin's Population Pharmacokinetics to Guide Dose Individualization in the Pediatric Population. Clinical pharmacokinetics 63 (7) (2024)
Elizabeth J Thompson, Angela Jeong, Victória Etges Helfer, Valentina Shakhnovich, Andrea N Edginton, Stephen J Balevic, Laura P James, David N Collier, Ravinder Anand, Daniel Gonzalez, null null
Physiologically-based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population. CPT: pharmacometrics & systems pharmacology (2024)
Patricia D Maglalang, Jiali Wen, Christoph P Hornik, Daniel Gonzalez
Sources of pharmacokinetic and pharmacodynamic variability and clinical pharmacology studies of antiseizure medications in the pediatric population. Clinical and translational science 17 (4) (2024)
Fernando O Carreño, Jacqueline G Gerhart, Victória Etges Helfer, Jaydeep Sinha, Karan R Kumar, Carl M J Kirkpatrick, Christoph P Hornik, Daniel Gonzalez, null null
Characterizing Enoxaparin's Population Pharmacokinetics to Guide Dose Individualization in the Pediatric Population. Clinical pharmacokinetics 63 (7) (2024)
Patricia D Maglalang, Jiali Wen, Christoph P Hornik, Daniel Gonzalez
Sources of pharmacokinetic and pharmacodynamic variability and clinical pharmacology studies of antiseizure medications in the pediatric population. Clinical and translational science 17 (4) (2024)
Elizabeth J Thompson, Angela Jeong, Victória Etges Helfer, Valentina Shakhnovich, Andrea N Edginton, Stephen J Balevic, Laura P James, David N Collier, Ravinder Anand, Daniel Gonzalez, null null
Physiologically-based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population. CPT: pharmacometrics & systems pharmacology (2024)
Patricia D Maglalang, Jaydeep Sinha, Kanecia O Zimmerman, Sean McCann, Andrea N Edginton, Christoph P Hornik, Chi D Hornik, William J Muller, Amira Al-Uzri, Marisa Meyer, Jia-Yuh Chen, Ravinder Anand, Eliana M Perrin, Daniel Gonzalez, null null
Application of Physiologically Based Pharmacokinetic Modeling to Characterize the Effects of Age and Obesity on the Disposition of Levetiracetam in the Pediatric Population. Clinical pharmacokinetics (2024)
Patricia D Maglalang, Jiali Wen, Christoph P Hornik, Daniel Gonzalez
Sources of pharmacokinetic and pharmacodynamic variability and clinical pharmacology studies of antiseizure medications in the pediatric population. Clinical and translational science 17 (4) (2024)
Elizabeth J Thompson, Kanecia O Zimmerman, Daniel Gonzalez, Henry P Foote, Sangah Park, Kevin D Hill, Jillian H Hurst, Chi D Hornik, Reid C Chamberlain, Rasheed A Gbadegesin, Christoph P Hornik
Population Pharmacokinetics of Caffeine in Neonates with Congenital Heart Disease and Associations with Acute Kidney Injury. Journal of clinical pharmacology (2023)
Sean McCann, Jaydeep Sinha, William S Wilson, Cameron J McKinzie, Lauren M Garner, Daniel Gonzalez
Population Pharmacokinetics of Posaconazole in Immune-Compromised Children and Assessment of Target Attainment in Invasive Fungal Disease. Clinical pharmacokinetics (2023)
Farwa Jafri, Zachary L Taylor, Daniel Gonzalez, Valentina Shakhnovich
Effects of obesity on the pharmacology of proton pump inhibitors: current understanding and future implications for patient care and research. Expert opinion on drug metabolism & toxicology (2023)
J Robert Powell, Farah Al Qaraghuli, Jill Fiedler-Kelly, Daniel Gonzalez, Daniel Weiner
Dabigatran Dosing Proposal for Adults with Atrial Fibrillation: Stress-testing Renal Function Range in Real World Patients. Clinical pharmacology and therapeutics (2023)
Jacqueline G Gerhart, Fernando O Carreño, Jennifer Lynn Ford, Andrea N Edginton, Eliana M Perrin, Kevin M Watt, William J Muller, Andrew M Atz, Amira Al-Uzri, Paula Delmore, Daniel Gonzalez, null null
Use of physiologically-based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity. CPT: pharmacometrics & systems pharmacology 11 (6) (2022)
Jacqueline G Gerhart, Fernando O Carreño, Matthew Shane Loop, And Craig R Lee, Andrea N Edginton, Jaydeep Sinha, Karan R Kumar, Carl M J Kirkpatrick, Christoph P Hornik, Daniel Gonzalez, null null
Use of Real-World Data and Physiologically-Based Pharmacokinetic Modeling to Characterize Enoxaparin Disposition in Children With Obesity. Clinical pharmacology and therapeutics 112 (2) (2022)
Daniel Gonzalez, Jaydeep Sinha
Pediatric Drug-Drug Interaction Evaluation: Drug, Patient Population, and Methodological Considerations. Journal of clinical pharmacology (2022)
Sara N Salerno, Edmund V Capparelli, Helen M McIlleron, Jacqueline G Gerhart, Julie B Dumond, Angela D M Kashuba, Paolo Denti, Daniel Gonzalez
Leveraging physiologically based pharmacokinetic modeling to optimize dosing for lopinavir/ritonavir with rifampin in pediatric patients. Pharmacotherapy (2022)
Daniel Weiner, J Robert Powell, J Herbert Patterson, Rachel Tyson, Anil Gehi, Stephan Moll, Robyn Konicki, Farah Al Qaraghuli, Kristen B Campbell, Angela D M Kashuba, Daniel Gonzalez
Leveraging a Previously Published Population Pharmacokinetic Model to Predict Rivaroxaban Exposure in Real-World Patients. Journal of clinical pharmacology 62 (12) (2022)
Eleni Karatza, Apostolos Papachristos, Gregory B Sivolapenko, Daniel Gonzalez
Machine learning-guided covariate selection for time-to-event models developed from a small sample of real-world patients receiving bevacizumab treatment. CPT: pharmacometrics & systems pharmacology 11 (10) (2022)
Samit Ganguly, Andrea N Edginton, Jacqueline G Gerhart, Michael Cohen-Wolkowiez, Rachel G Greenberg, Daniel Gonzalez, null null
Physiologically Based Pharmacokinetic Modeling of Meropenem in Preterm and Term Infants. Clinical pharmacokinetics 60 (12) (2021)
Jing 'Daisy' Zhu, Yi Shuan Shirley Wu, Ryan J Beechinor, Ryan M Kemper, Laura H Bukkems, Ron A A Mathot, Marjon H Cnossen, Daniel Gonzalez, Sheh-Li Chen, Nigel S Key, Daniel J Crona
Pharmacokinetics of perioperative FVIII in adult patients with haemophilia A: An external validation and development of an alternative population pharmacokinetic model. Haemophilia : the official journal of the World Federation of Hemophilia 27 (6) (2021)
Jacqueline G Gerhart, Fernando O Carreño, Andrea N Edginton, Jaydeep Sinha, Eliana M Perrin, Karan R Kumar, Aruna Rikhi, Christoph P Hornik, Vincent Harris, Samit Ganguly, Michael Cohen-Wolkowiez, Daniel Gonzalez, null null
Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic Modeling. Clinical pharmacokinetics (2021)
Ryan J Beechinor, Patrick A Thompson, Michael F Hwang, Ryan C Vargo, Lisa R Bomgaars, Jacqueline G Gerhart, ZoAnn E Dreyer, Daniel Gonzalez
The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children's Oncology Group. Clinical pharmacokinetics 58 (7) (2020)
Stephen J Balevic, Christoph P Hornik, Thomas P Green, Megan E B Clowse, Daniel Gonzalez, Anil R Maharaj, Laura E Schanberg, Amanda M Eudy, Geeta K Swamy, Brenna L Hughes, Michael Cohen-Wolkowiez
Dr. Balevic, et al reply. The Journal of rheumatology 47 (10) (2020)
Robyn Konicki, Daniel Weiner, J Herbert Patterson, Daniel Gonzalez, Angela Kashuba, Yanguang Carter Cao, Anil K Gehi, Paul Watkins, J Robert Powell
Rivaroxaban Precision Dosing Strategy for Real-World Atrial Fibrillation Patients. Clinical and translational science 13 (4) (2020)
Daniel Gonzalez, Matthew M Laughon, P Brian Smith, Shufan Ge, Namasivayam Ambalavanan, Andrew M Atz, Gregory M Sokol, Chi D Hornik, Dan Stewart, Gratias Mundakel, Brenda B Poindexter, Roger Gaedigk, Mary Mills, Michael Cohen-Wolkowiez, Karen Martz, Christoph P Hornik, null null
Population pharmacokinetics of sildenafil in extremely premature infants. British journal of clinical pharmacology 85 (12) (2019)
Nilay Thakkar, Sara Salerno, Christoph P Hornik, Daniel Gonzalez
Clinical Pharmacology Studies in Critically Ill Children. Pharmaceutical research 34 (1) (2016)

Daniel Gonzalez.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel Gonzalez